Insulin Edema in a Patient With Cystic Fibrosis–Related Diabetes
- Katherine S. O'Neal, PHARMD, MBA, CDE1,
- Bethany A. Francis, BA2,
- Michelle E. Condren, PHARMD, AE-C, CDE3 and
- Laura J. Chalmers, MD4
- 1University of Oklahoma College of Pharmacy, Tulsa, Oklahoma
- 2University of Oklahoma College of Pharmacy, Tulsa, Oklahoma
- 3University of Oklahoma College of Pharmacy, Tulsa, Oklahoma
- 4University of Oklahoma School of Community Medicine, Tulsa, Oklahoma
- Corresponding author: Katherine S. O'Neal, katherine-oneal{at}ouhsc.edu.
Insulin edema is a rare complication of insulin therapy primarily seen with newly diagnosed or uncontrolled diabetes (1–3). Patients at risk are those who are beginning insulin treatment, underweight, or increasing their insulin dose either in the normal course of the disease or after diabetic ketoacidosis (1,4). The prevalence of insulin edema is unknown; a review of the literature revealed few case reports of insulin edema and no reports of insulin edema in a patient with cystic fibrosis–related diabetes (CFRD). This case report illustrates the effects of insulin edema in a 23-year-old female patient who was diagnosed with CFRD at the age of 16 years.
The patient presented to the pediatric endocrine clinic at the age of 16 years with an HbA1c of 9.8%. She …
In this Issue
